Gilliland Robertson H.
Insider CIK 1718351 · ADIL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2026-04-07 | 2026-04-09 | 9,185 | — | $0 | 9,185 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2025-05-29 | 2025-06-02 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2024-03-25 | 2024-03-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2023-05-23 | 2023-05-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2022-02-23 | 2022-02-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2021-02-08 | 2021-02-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2020-03-03 | 2020-03-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | P Buy deriv | 2018-07-31 | 2018-08-02 | 14,000 | — | $0 | 43,931 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | C Conversion deriv | 2018-07-31 | 2018-08-02 | 29,931 | — | $0 | 29,931 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | C Conversion deriv | 2018-07-31 | 2018-08-02 | 29,931 | — | $0 | 0 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | C Conversion | 2018-07-31 | 2018-08-02 | 29,931 | — | $0 | 95,424 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | P Buy | 2018-07-31 | 2018-08-02 | 14,000 | — | $0 | 109,424 | SEC↗ |